Avenda Health’s Unfold AI Included in Expanded Medicare Physician Fee Schedule Across West Coast and Mountain West Regions
Unfold AI’s inclusion in physician fee schedules across Western markets helps broaden access to AI-guided prostate cancer care, enabling more precise treatment planning
- The 3D AI cancer mapping and clinical decision-making platform is reimbursable by Medicare in physician office settings in California, Arizona, Utah, Nevada, Oregon, Washington, and Idaho.
- This milestone comes after physicians using Unfold AI began receiving Medicare reimbursement in 2025.
- Clear reimbursement pathways to Unfold AI improves access to a powerful tool that improves diagnostic and treatment planning accuracy.
CULVER CITY, Calif., April 23, 2026 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announces Unfold AI is now included in Medicare’s Physician Fee Schedules across the West Coast and Mountain West regions. The regional expansion of Medicare payment for Avenda’s AI prostate cancer mapping and clinical decision support platform gives urologists and care teams clearer reimbursement pathways in physician office settings, an area that has historically lagged behind hospital outpatient settings for emerging technologies.
